Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expensify Inc (EXFY) vs UiPath Inc (PATH) Price & Performance

Expensify IncTrade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

Expensify Inc vs UiPath Inc — how do they compare? Expensify Inc trades at $1.76 (market cap $170.21M), while UiPath Inc trades at $11.47 (market cap $6.19B). The key difference: UiPath Inc is far larger — about 36.4× Expensify Inc's market cap, and Expensify Inc is trading nearer its 52-week high, UiPath Inc nearer its low. Which is the better fit depends on your goals.

EXFYPATH
Market Cap
$170.21M$6.19B
Sector
TechnologyTechnology
52-Week High
$2.33$19.29
52-Week Low
$0.75$9.38
Enterprise Value
$109.24M$4.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expensify Inc

Expensify (EXFY) trades at $1.755, down 3.04% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.04, beating expectations, but maintains negative profitability metrics with a -14.68% net income margin. Recent developments include AI-powered expense management expansions and a $25 million stock repurchase program, indicating strategic initiatives to drive growth.

The outlook remains cautious due to persistent unprofitability despite revenue stabilization around $140 million. Investment opportunities lie in operational efficiency gains and new product integrations, but risks include competitive pressure and the challenge of achieving sustainable profitability. Analyst sentiment is divided with equal buy/hold ratings, reflecting uncertainty about the company's turnaround potential.

UiPath Inc

UiPath (PATH) trades at $11.94, up 0.76% with a bullish technical outlook and strong support at $11. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while transitioning from losses to profitability. Recent earnings show mixed results with Q2 2026 expectations at $0.15 EPS. The stock trades below analyst consensus target of $13.33, representing potential upside from current levels.

PATH presents a compelling turnaround story with improving profitability and strong gross margins above 80%. Key risks include execution challenges in AI monetization and competitive pressures in enterprise automation. The 25% upside to consensus target and improving cash flow trends support a constructive outlook, though investors should monitor Q2 earnings delivery and enterprise adoption of Maestro AI capabilities.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Expensify Inc

Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Read more on EXFY

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH